Can we better select patients with metastatic renal cell carcinoma for cytoreductive nephrectomy

Cancer6.20
Volume: 116, Issue: 14, Pages: 3378 - 3388
Published: Jul 15, 2010
Abstract
BACKGROUND: The benefits of cytoreductive nephrectomy (CN) in metastatic renal cell carcinoma (mRCC) should outweigh surgical morbidity. Even when the generally agreed upon selection criteria for CN are met, some patients do poorly after surgery. The objective of this study was to identify preoperative factors that were prognostic of outcome in patients who were being considered for CN. METHODS: The authors conducted a retrospective study...
Paper Details
Title
Can we better select patients with metastatic renal cell carcinoma for cytoreductive nephrectomy
Published Date
Jul 15, 2010
Journal
Volume
116
Issue
14
Pages
3378 - 3388
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.